Fund Research for GMO International Growth Equity IV (GMGFX)

  • Fund Overview

    Fund Inception Date: Jul 12, 2006
    Category: Foreign Large Blend
    Overall Risk: Low
    Fund Family: GMO
    Return Since Inception: -0.99%
    YTD Return: 21.38%
    Yield (TTM): 4.05%
    Net Assets: 2.08 B
    Morningstar Rating:
    4 of 5

    The investment seeks high total return. The fund generally invests in a diversified portfolio of equity investments from developed markets outside of the U.S. Under normal circumstances, it invests at least 80% of assets in equity investments.

    You need a current version of Adobe Flash Player plugin to view this chart.

    Get Adobe Flash player
    Size
    Average Market Cap $25,685 M
    Market Capitalization Portfolio
    Giant 54.94%
    Large 31.28%
    Medium 13.47%
    Small 0.31%
    Micro 0.00%
    Morningstar Rating as of 10/31/2009
    YTD Returns as of 11/27/2009    		 Style Box Detail calculations do not include the fund's short positions (if any)

  • Fund Performance

    10 year Growth Chart
    Growth of $10,000 from 07/31/2006 to 10/31/2009
    Mouseover the chart to see values for each month.

    You need a current version of Adobe Flash Player plugin to view this chart.

    Get Adobe Flash player

    Total Annualized Returns

    YTD 1 year 3 year 5 year 10 year Since Inception
    Fund 21.38% 32.19% -2.53% — — -0.99%
    +/- Category -7.46% -6.55% 2.63% — — —
    +/- MSCI EAFE NR USD — — — — 2.04% —

    Standardized Annual Returns

    YTD 1 year 3 year 5 year 10 year Since Inception
    Month (as of 10/31/2009) 16.73% 19.31% -3.64% 5.41% — -0.99%
    Quarter (as of 09/30/2009) 17.67% 0.19% -2.12% — — -0.77%
    Fund and Category YTD, 1yr, 3yr and 5yr Returns as of 11/27/2009
    Index YTD,1yr, 3ys and 5yr Returns as of 11/27/2009 10 yr and Since Inception Returns as of 10/31/2009
    Inception Date: 07/12/2006
    Ratings are based on risk-adjusted performance.
    View Total Returns

  • Fund Portfolio Profile

    Sector Breakdown

    Stocks
    Information 13.48%
    Service 43.46%
    Manufacturing 35.81%

    Asset Allocation

    Short Long Net Assets
    Cash 19.26% 21.82% 2.57%
    Stocks 1.62% 98.09% 96.46%
    Bonds 0.00% 0.00% 0.00%
    Other 0.00% 0.00% 0.00%
    Foreign Stocks
    (as a % of assets)    		 1.62% 98.09% 96.46%
    Data as of 08/31/2009 Data as of 08/31/2009 View Fund Portfolio

    Top 10 Holdings

    Sector Country Net Assets
    + Novartis Healthcare CHE 4.61%
    + GlaxoSmithKline PLC (GLAXF) Healthcare GBR 4.51%
    - Nestle (NESN) Consumer Goods CHE 3.58%
    + Roche Holding AG (RHHVF) Healthcare CHE 2.84%
    + Telefonica, S.A. (TEF) Telecom ESP 2.75%
    + Sanofi-Aventis (SAN) Healthcare FRA 2.52%
    * Reckitt Benck Grp Consumer Goods GBR 2.51%
    * Jpy/Usd Fwd 20090626 000006747 Usd — — 2.33%
    * Usd/Jpy Fwd 20090626 000006747 Usd — — 2.27%
    - BG Group PLC (BG.) Energy GBR 2.22%
    + Increase - Decrease = No change * New since last portfolio
    Top 10 holdings account for the fund's short positions (if any). Net short positions appear shaded.
    Data as of 05/31/2009
    View Fund Portfolio

  • Sales Information

    Sales Charge %

    Initial —
    Deferred —
    Taken from prospectus dated 09/24/2009
    Expense Ratio (based on net assets) 0.60%
    Taken from annual report dated 02/28/2009

  • Fund Management